Aptamers Market – Technology Trend Analysis By Applications – Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis – Global Forecasts to 2018

Publisher Name :
Date: 5-Jul-2013
No. of pages: 171
Inquire Before Buying

Aptamers is an emerging market, widely considered as a rival or substitute to antibodies in the scientific industry. It is poised to grow rapidly in various application areas, including therapeutics and diagnostics. The global aptamers market is valued at $287 million in 2013 and is expected to reach $2.1 billion by 2018.

Aptamers existed in parallel with antibodies for two decades, but its market potential was not utilized, even to a fraction of antibodies. However, the achievement of Macugen has given a boost to the aptamer field. The list of promising aptamers in the clinical trials pipeline estimates that these synthetic chemical antibodies will soon surpass monoclonal antibodies in therapeutics, diagnosis, and imaging. With technological merits over antibodies, the aptamers market is poised to grow at par with antibodies in the next 10-15 years.

Though there are just < 60 companies (biotech and pharmaceutical) working on aptamers, there are quite a number of research groups working on diverse applications of aptamers, particularly in studying key target molecules involved in cardiovascular diseases, infectious diseases, and against viral antigens. Hundreds of research articles have been published and a lot of patents granted and filed for this technology.

The aptamers market is analyzed both in terms of qualitative, i.e. technological and quantitative, i.e. revenue, perspectives. The technological analysis includes discussion on inherent characteristics and capabilities of aptamers over antibodies and the various applications where aptamers can find its place. The market revenue analysis includes market segmentation and the expected market position by 2018, with the projected growth rate.

The aptamers market is classified by geography, application segments and aptamer type. The application segments are further divided as therapeutics, diagnostics, biosensors, drug discovery, biomarker discovery, and research applications. The advantages of chemically modified aptamers and low production cost compared to antibodies aid the growth of the market. However, the reduced market acceptance compared to the antibodies and increased time consumption for screening using SELEX will hamper the growth of this market, to a certain extent. While aptamer technology has existed for over two decades, the challenges imposed on the development of aptamers for small molecules has resulted in very few novel aptamers that can bind to practical small molecular targets. Nevertheless, there are many opportunities for the innovative application of small molecule binding aptamers in biosensing, drug discovery, diagnostics and therapeutics.

Besides a discussion on the properties of aptamers in the technological analysis, the basics on nucleic acid aptamers, peptide aptamers and the SELEX method for their synthesis are also discussed. Research applications are specifically discussed regarding aptamers use in flow cytometry, reagents and assays, mass spectrometry and western blotting. In addition, a number of therapeutic targets that are validated by basic research have been displayed under the therapeutics application segment. The complete value chain of the aptamers market is schematically represented and the significance of each stakeholder has been briefed.

Apart from the technological and market analysis, the investor climate has been assessed by tracking the complete investor network and collecting data on funds/grants and investments made towards the aptamers. Insights on current and future technological investment trends have also been discussed.

The adoption and developmental potential of the aptamers technology market has been discussed on a geographic basis, i.e. North America, Europe, Asia-Pacific, and Rest of the world, by taking select countries that are poised to have a greater market value during the forecast period.

In brief, this research report provides:

  • A detailed description of the global technology developments and evolving trends in the aptamers field with key prominence on research innovations, collaborative efforts, and investments for aptamers.
  • A close view on the aptamer based drug development for treatment of specific diseases by providing details and status of current aptamer drugs in pipeline.
  • An impact analysis of major drivers and restraints influencing the adoption and growth of the aptamers market during the period of 2013to 2018.
  • Porters five forces analysis and SWOT analysis.
  • Market size – global market forecast for 2013-2018, including demand side analysis and strategic recommendations for technology/product developers.
  • Competitive landscape based on the analysis of key patents and research publications.

Scope of the Report

This research report categorizes the global aptamers market into geography, applications, and aptamer type. The applications market is further broken down by geography, with exhaustive revenue analysis for 2012 and 2013, as well as the forecast up to 2018.

Global Aptamers Market – By Application

  • Therapeutics
  • Diagnostics
  • Biosensors
  • Drug discovery
  • Biomarker discovery
  • Research applications

Global Aptamers Market – By Aptamer Type

  • Nucleic acid aptamers
  • Peptide aptamers

Global Aptamers Market – By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)

Aptamers Market – Technology Trend Analysis By Applications – Therapeutics, Diagnostics, Biosensors, Drug Discovery, Biomarker Discovery, Research Applications with Market Landscape Analysis – Global Forecasts to 2018

Table Of Contents

1 Introduction
1.1 Logical Assumptions In This Study Based On Reliable Sources
1.2 Key Take-Aways
1.3 Report Scope
1.4 Research Methodology
1.5 Key Data Points From Secondary And Primary Sources

2 Executive Summary

3 Aptamers – Technology Landscape Analysis
3.1 Technology Overview
3.2 History & Milestones Of Aptamers
3.3 Aptamers Vs Antibodies
3.4 Aptamer Types
3.4.1 Nucleic Acid Aptamers
3.4.2 Peptide Aptamers
3.5 Aptamer Synthesis & Modifications
3.6 Applications
3.6.1 Therapeutics
3.6.1.1 Different Targets Of Therapeutic Interest
3.6.2 Diagnostics
3.6.3 Biosensors
3.6.4 Drug Discovery
3.6.5 Biomarker Discovery
3.6.6 Research Applications
3.6.6.1 Reagents & Assays
3.6.6.2 Flow Cytometry
3.6.6.3 Mass Spectrometry
3.6.6.4 Western Blotting
3.7 Technology Value Chain Analysis
3.8 Aptamers – Technology Innovations And Products With Applications

4 Aptamers – Market Landscape Analysis
4.1 Aptamers Market Segmentation
4.2 Aptamers Technology - Global Impact
4.3 Market Forecast (2013 - 2018) – Overview
4.4 Global Aptamers Market Revenue Forecast (2013-2018)
4.4.1 Global Aptamers Market Revenue – By Geography
4.4.1.1 North America
4.4.1.2 Europe
4.4.1.3 Asia Pacific
4.4.1.4 Rest Of The World
4.4.2 Global Aptamers Market Share – By Geography
4.4.2.1 North America
4.4.2.2 Europe
4.4.2.3 Asia Pacific
4.4.2.4 Rest Of The World
4.4.3 Global Aptamers Market Revenue – By Application Segments
4.4.3.1 Global Aptamers Market Share – By Segments
4.4.3.2 Therapeutic Aptamers Market – By Region
4.4.3.3 Diagnostics Aptamers Market – By Region
4.4.3.4 Biosensors Aptamers Market – By Region
4.4.3.5 Drug Discovery Aptamers Market – By Region
4.4.3.6 Aptamers Biomarker Discovery Market – By Region
4.4.3.7 Aptamers Research Applications Market – By Region
4.4.4 Global Aptamers Market Revenue – By Aptamer Type
4.4.4.1 Nucleic Acid Aptamer Market – By Region
4.4.4.2 Peptide Aptamer Market – By Region
4.4.4.3 Nucleic Acid And Peptide Aptamers Market Share – By Region
4.5 Market Dynamics
4.5.1 Drivers - Explanation
4.5.1.1 Impact Analysis By Timeline
4.5.2 Restraints – Explanation
4.5.2.1 Impact Analysis By Timeline
4.6 SWOT Analysis
4.7 Porter’s Five Forces Analysis

5 Technology Investment Potential
5.1 Investment Climate Assessment
5.2 Investor Network
5.3 Some Funds And Investments On Aptamers
5.4 Some Funds And Investments From Nih – By Fiscal Year
5.5 Some Funds And Investments From Nih – By Its Associated Institutes/Centers (FY 2008-2013)
5.6 Insights On Current And Future Tech-Investment Trends

6 Aptamers – Technology Adoption And Development Potential
6.1 Geographic Adoption And Development Potential - Overview
6.2 North America
6.3 Europe
6.4 Asia-Pacific
6.5 Row – Selected Countries
6.6 Demand Side Analysis
6.7 Technology Roadmap

7 Aptamers Competitive Landscape
7.1 Competitive Landscape Analysis
7.2 Key Acquisitions/Partnerships/Agreements/Collaborations (2009 – 2013)
7.3 Startups And Spinoff’s Based On Aptamers Technology
7.4 Clinical Trials Of Aptamers – By Different Properties (Anti-Coagulant Aptamers, Anti-Angiogenic Aptamers, Anti-Oncogenic Aptamers, Anti-Diabetic Aptamers)
7.4.1 Apamer Based Drugs In Clinical Trials

8 Intellectual Property And Research Strength Analysis
8.1 Selected Aptamer And Selex Patents
8.2 IP Strength Analysis Of Aptamers
8.3 Proprietary Technologies Based On Aptamers

9 Analyst Insights And Recommendations
9.1 Analyst Insights
9.2 Strategic Recommendations For Technology & Business Investors
9.3 Open Opportunity Invitations In The Field For Business Development

10 Company Profiles
10.1 AM Biotechnologies, Llc
10.2 Aptagen, LIC
10.3 Aptamer Sciences Inc.
10.4 Aptamer Solutions Ltd
10.5 Aptares AG
10.6 Base Pair Biotechnologies
10.7 Integrated Dna Technologies, Inc
10.8 Neoventures Biotechnology Inc.
10.9 NOXXON Pharma AG
10.10 OTC Biotech
10.11 Somalogic, Inc.
10.12 Trilink Biotechnologies, Inc.
10.13 Vivonics
10.14 Pfizer
10.15 Aptamatrix, Inc.
10.16 Aptusbiotech
10.17 Bioapter S.L.
10.18 Cd Genomics
10.19 Lucerna, Inc.
10.20 Ophthotech Corporation
10.21 Regado Biosciences, Inc.

List Of Tables

Tab - 1 Global Aptamers Market, 2013 - 2018 ($Million)
Tab - 2 Global Aptamers Market, By Geography, 2013 - 2018 ($Million)
Tab - 3 Global Aptamers Market Revenue, By Application Segment, 2013 - 2018 ($Million)
Tab - 4 Therapeutic Aptamers Market, By Geography, 2013 - 2018 ($Million)
Tab - 5 Diagnostics Aptamers Market, By Region, 2013 - 2018 ($Million)
Tab - 6 Biosensor Aptamers Market, By Geography, 2013 - 2018 ($Million)
Tab - 7 Drug Discovery Aptamers Market, By Geography, 2013 - 2018 ($Million)
Tab - 8 Aptamers Biomarker Discovery Market, By Geography, 2013 - 2018 ($Million)
Tab - 9 Aptamers Research Applications Market, By Geography, 2013 - 2018 ($Million)
Tab - 10 Global Aptamers Market, By Type, 2013 - 2018 ($Million)
Tab - 11 Nucleic Acid Aptamers Market, By Geography, 2013 - 2018 ($Million)
Tab - 12 Peptide Aptamers Market, By Geography, 2013 - 2018 ($Million)
Tab - 13 Funds By Nih & Associated Centers 2008-2013 ($Million)
Tab - 14 Projects And Funds By Nih & Associated Centers 2008-2013 ($Million)

List Of Figures

Fig - 1 Global Market Of Aptamers 2013 – 2018 ($Million)
Fig - 2 Global Market Of Aptamers 2013 – 2018 ($Million)
Fig - 3 Global Aptamers Market Revenue, By Geography, 2013 – 2018 ($Million)
Fig - 4 Global Aptamers Market Share By Geography, 2013
Fig - 5 Global Aptamers Market Share By Geography, 2018
Fig - 6 Global Aptamers Technology Market Revenue, By Applications, 2013 – 2018 ($Million)
Fig - 7 Global Aptamers Technology Market Share, By Applications, 2013 – 2018
Fig - 8 Global Aptamers Market Share By Segments, 2013
Fig - 9 Global Aptamers Market Share By Segments, 2018
Fig - 10 Therapeutic Aptamers Market, By Region, 2013 – 2018 ($Million)
Fig - 11 Therapeutic Aptamer Market By Region, 2013
Fig - 12 Therapeutic Aptamer Market By Region, 2018
Fig - 13 Diagnostics Aptamers Market, By Region, 2013 – 2018 ($Million)
Fig - 14 Diagnostics Aptamers Market By Region, 2013
Fig - 15 Diagnostics Aptamers Market By Region, 2018
Fig - 16 Biosensor Aptamers Market, By Region, 2013 – 2018 ($Million)
Fig - 17 Biosensor Aptamers Market By Region, 2013
Fig - 18 Biosensor Aptamers Market By Region, 2018
Fig - 19 Drug Discovery Aptamers Market, By Region, 2013 – 2018 ($Million)
Fig - 20 Drug Discovery Aptamers Market By Region, 201380
Fig - 21 Drug Discovery Aptamers Market By Region, 201880
Fig - 22 Aptamers Biomarker Discovery Market, By Region, 2013 – 2018 ($Million)
Fig - 23 Aptamers Biomarker Discovery Market By Region, 2013
Fig - 24 Aptamers Biomarker Discovery Market By Region, 2018
Fig - 25 Aptamers Research Applications Market, By Region, 2013 – 2018 ($Million)
Fig - 26 Aptamers Research Applications Market By Region, 2013
Fig - 27 Aptamers Research Applications Market By Region, 2018
Fig - 28 Global Aptamers Market, Nucleic Acid Aptamer, 2013 – 2018 ($Million)
Fig – 29 Global Aptamers Market, Peptide Aptamer, 2013 – 2018 ($Million)

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • U.S. Wound and Tissue Management Market – 2014
    Published: 1-Oct-2014        Price: US $6995 Onwards        Pages: 353
    The U.S. market for wound and tissue management includes any device that treats wounds to the skin including the, dermal layers and adjacent subcutaneous tissues in addition to devices that manage trauma to tissue and blood vessels during surgery. This market includes wound closure devices, static compression therapy, dynamic compression therapy, advanced dressings, hemostats, tissue sealants, anti-adhesion products and negative wound pressure therapy.In the past few years technology has develop......
  • Global High Throughput Screening (HTS) Market 2014-2018
    Published: 1-Oct-2014        Price: US $2500 Onwards        Pages: 91
    About High Throughput Screening High throughput screening (HTS) is a technology of screening and analyzing a large number of biological or chemical compounds against specific targets. It is generally a fully automated technology and involves instruments, consumables, and software for screening and analysis of compound. The use of liquid handling devices, robotics, and bioinformatics are important aspects of the HTS technology. It is widely used by researchers for drug discovery and other resear......
  • Glycobiology/Glycomics Market by Product [Enzymes (Glycosyltransferase, Neuraminidase, Glycosidase), Instruments (HPLC, Mass Spectrometry, MALDI-TOF), Kits, and Reagents], Application (Immunology, Oncology) & by End User – Global Forecast to 2019
    Published: 30-Sep-2014        Price: US $4650 Onwards        Pages: 214
    Glycomics is the study of carbohydrates and carbohydrate-containing biomolecules in biological processes such as cell recognition, immune response, cell-to-cell interaction, infection and inflammation. These processes are dependent on the intricate glycan structures present on interacting biomolecules. Advanced technologies such as high-throughput mass spectroscopy, glycan microarrays, and carbohydrate chemistry are helping to unravel the complexity resulting from this diversity. This report ......
  • Epigenetics Market by Product (Modifying Enzymes, DNA Polymerase, Acetylase, Methyltransferase, Instruments & Consumables, Kit, Bisulphite Conversion Kit, Reagents), Research Area (Developmental Biology, Oncology) & by End User – Global Forecast to 2019
    Published: 29-Sep-2014        Price: US $4650 Onwards        Pages: 200
    In this report, the global epigenetics market is segmented on the basis of products, research areas, and end users. The product segments of the epigenetics market included in this report are enzymes, instruments & consumables, kits, and reagents. The subsegments of the enzymes product segment are DNA-modifying enzymes (DNA ligases, DNA polymerases and other DNA-modifying enzymes); protein-modifying enzymes (acetylases, methyltransferases and other protein-modifying enzymes); and RNA-modifyin......
  • Latest Chinese Guidebook for Application and Approval of Imported In-vitro Diagnostic Reagent Registration: From Regulations to Practices (2014 Edition)
    Published: 28-Sep-2014        Price: US $1495 Onwards        Pages: 208
    Summary China’s regulatory framework for in-vitro diagnostic reagents is undergoing earthshaking changes. The country’s new leaders have recognized that the regulations for supervision and administration of in-vitro diagnostic reagents are far from perfect along with rapid population growth and thriving economy over the past 30 years. Chinese state council issued the latest “Regulations for the Supervision and Administration of Medical Devices” on February 12, 2014, and it has come in......
  • RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) – Global Forecast to 2019
    Published: 26-Sep-2014        Price: US $4650 Onwards        Pages: 300
    The global transcriptomics market is expected to grow at a CAGR of 13.7% during the forecast period of 2014 to 2019 and is estimated to be worth $3,773.0 million by 2019. The transcriptomics market has blatantly grown in the past few years primarily due to the increasing technological advancements in the field of sequencing technologies in transcriptomics research. Similarly, the increasing government and private funding for research coupled with research and development investments by the biote......
  • Laboratory Filtration Market by Technology (Ultrafiltration, Microfiltration, Reverse Osmosis), Product (Filter Assembly, Filter Media), Accessories (Dispenser, Seal, Filter Flask, Vacuum Pump) & by End-User – Global Forecasts to 2019
    Published: 25-Sep-2014        Price: US $4650 Onwards        Pages: 200
    Over the last decade, the laboratory filtration market is experiencing growth primarily due to rising R&D budgets and increased acceptance of new filtration technologies in end users market. The fast growing pharmaceutical and biotechnology industries are also catalyzing the growth of laboratory filtration market. In this report, the global laboratory filtration market is segmented by technology, products, accessories, and geography. The laboratory filtration market is mainly classified b......
  • Omega-3 PUFA Market by Type (DHA, EPA, ALA), Source[Marine (Fish, Algal, Krill, Others), Plant (Flaxseed, Chia Seed, Others)], Application (Dietary supplement, Functional F&B, Pharma, Infant Formula, Others) & Geography – Global Trend & Forecast to 2019
    Published: 24-Sep-2014        Price: US $4650 Onwards        Pages: 180
    The Omega-3 PUFA market is poised to exhibit a strong growth in the next five years. Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are rapidly growing types of Omega-3 PUFA and also garner the largest market share. The market for DHA and EPA is growing due to its health claims and the specific role they play in the prevention of cardio-vascular health, infant nutrition, and cancer. Fish oils are the major source of Omega-3 PUFA and account for 70% of the Omega-3 PUFA market. Omega-3......
  • Cell Isolation/Cell Separation Market by Product (Reagent, Media, Bead, centrifuge), Cell Type (human, stem cell, animal), Technique (Filtration, Surface Marker), Application (Research, IVD) & by End user (Hospital, Biotechnology) – Forecast to 2019
    Published: 24-Sep-2014        Price: US $4650 Onwards        Pages: 211
    The global cell isolation market is expected to reach $5.1 billion by 2019 from $2.5 billion in 2014, growing at a CAGR of 15.8% from 2014 to 2019. The global cell isolation market is categorized on the basis of product, cell type, technique, application, end user, and geography. The human cell isolation segment is expected to register the highest growth rate in the cell isolation market, by cell type, during the forecast period. Its favorable growth is attributed to increasing focus on human st......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs